INTEGRA LIFESCIENCES HOLDINGS CORP Research and Development in Process
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Research and Development in Process of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2022-02-24
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development in process for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development in process for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development in process for the quarter ending 2019-12-31 was $5.03M.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development in process for the quarter ending 2019-09-30 was $59.89M.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development in process for fiscal 2021 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development in process for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development in process for fiscal 2019 was $64.92M.
- INTEGRA LIFESCIENCES HOLDINGS CORP research and development in process for fiscal 2018 was $0.00.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 9 month as first filed | Research and Development in Process 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-24 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | ||
| 2020-09-30 | $0.00 10-Q · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | |||
| 2019-12-31 | $5.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $64.92M derived: sum of 2 quarters · filed 2022-02-24 | $64.92M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $59.89M 10-Q · filed 2020-10-29 | $59.89M 10-Q · filed 2020-10-29 | $61.57M 10-Q · filed 2019-10-25 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $0.00 derived: sum of 2 quarters · filed 2021-02-23 | $0.00 10-K · filed 2021-02-23 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-10-25 | $0.00 10-Q · filed 2019-10-25 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-21 | ||||
| 2010-12-31 | $0.00 10-K · filed 2011-02-24 | ||||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $277.00K 10-K · filed 2012-02-27 | |||
| 2009-09-30 | $277.00K 10-Q · filed 2010-10-28 | ||||
| 2008-12-31 | $25.24M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |